SRA's number for the day: 69
This article was originally published in SRA
Executive Summary
The European Commission has authorized 69 orphan medicines to date and granted more than 1,000 orphan designations1. The orphan designation permits a company to benefit from the many incentives provided in the EU legislation to develop medicines for rare diseases.